146 related articles for article (PubMed ID: 28059167)
21. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
22. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
23. Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.
Tiago DM; Conceição N; Caiado H; Laizé V; Cancela ML
FEBS Lett; 2016 Apr; 590(8):1234-41. PubMed ID: 27009385
[TBL] [Abstract][Full Text] [Related]
24. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
25. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
26. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
27. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
28. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
29. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Kloten V; Schlensog M; Eschenbruch J; Gasthaus J; Tiedemann J; Mijnes J; Heide T; Braunschweig T; Knüchel R; Dahl E
PLoS One; 2016; 11(7):e0159073. PubMed ID: 27400234
[TBL] [Abstract][Full Text] [Related]
30. Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression.
Canzoneri R; Rabassa ME; Gurruchaga A; Ferretti V; Palma S; Isla-Larrain M; Croce MV; Lacunza E; Abba MC
Oncol Rep; 2018 Aug; 40(2):909-915. PubMed ID: 29901166
[TBL] [Abstract][Full Text] [Related]
31. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer.
Nagao K; Kohno N; Wakita K; Hikiji K; Yamamoto S; Hirata H; Hisatomi H
Oncol Rep; 2003; 10(2):305-8. PubMed ID: 12579263
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
33. Extensive transcriptional complexity during hypoxia-regulated expression of the myoglobin gene in cancer.
Bicker A; Dietrich D; Gleixner E; Kristiansen G; Gorr TA; Hankeln T
Hum Mol Genet; 2014 Jan; 23(2):479-90. PubMed ID: 24026678
[TBL] [Abstract][Full Text] [Related]
34. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
[TBL] [Abstract][Full Text] [Related]
36. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
37. Low methylation levels of the SFRP1 gene are associated with the basal-like subtype of breast cancer.
Jeong YJ; Jeong HY; Bong JG; Park SH; Oh HK
Oncol Rep; 2013 May; 29(5):1946-54. PubMed ID: 23467623
[TBL] [Abstract][Full Text] [Related]
38. EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
Semmlinger A; von Schoenfeldt V; Wolf V; Meuter A; Kolben TM; Kolben T; Zeder-Goess C; Weis F; Gallwas J; Wuerstlein R; Hermelink K; Schmoeckel E; Harbeck N; Mayr D; Mahner S; Jeschke U; Ditsch N
BMC Cancer; 2018 Apr; 18(1):431. PubMed ID: 29661238
[TBL] [Abstract][Full Text] [Related]
39. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling of ADAM12 gene in breast cancers.
Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
